GNRH2 and breast carcinoma: To analyze the effects of GnRH-II antagonist treatment on apoptotic signaling, GnRH-II antagonist-induced activation of stress activated MAPK p38 (Figure 2a) and caspase-3 (Figure 2b) in MCF-7 and MDA-MB-231 human breast cancer cells was measured.